Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.
Public ClinicalTrials.gov record NCT05690204. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2B Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of 3 Dosages of SAP-001 in Combination With Standard of Care in Adult Subjects With Gout
Study identification
- NCT ID
- NCT05690204
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Shanton Pharma Pte. Ltd.
- Industry
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Interventions
- SAP-001 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 11, 2022
- Primary completion
- Dec 31, 2024
- Completion
- Jan 31, 2025
- Last update posted
- Nov 13, 2024
2022 – 2025
United States locations
- U.S. sites
- 15
- U.S. states
- 8
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Site | Sacramento | California | 95821 | — |
| California Site | San Diego | California | 92119 | — |
| Denver Site | Denver | Colorado | 80230 | — |
| Florida Site | DeBary | Florida | 32713 | — |
| Florida Site | Miami | Florida | 33173 | — |
| Florida Site | Miami Lakes | Florida | 33014 | — |
| Florida Site | Miami Lakes | Florida | 33173 | — |
| Florida Site | Winter Park | Florida | 32789 | — |
| Idaho Site | Boise | Idaho | 83713 | — |
| Maryland Site | Oxon Hill | Maryland | 20745 | — |
| Mississippi Site | Jackson | Mississippi | 39202 | — |
| North Carolina Site | Raleigh | North Carolina | 27612 | — |
| Texas Site | Mesquite | Texas | 75150 | — |
| Texas Site | Plano | Texas | 75093 | — |
| Texas Site | The Woodlands | Texas | 77832 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05690204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 13, 2024 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05690204 live on ClinicalTrials.gov.